Gradient of Risk and Associations With Cardiovascular Efficacy of Ertugliflozin by Measures of Kidney Function: Observations From VERTIS CV

VERTIS-CV Investigators

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)602-605
Number of pages4
JournalCirculation
Volume143
Issue number6
DOIs
StatePublished - Feb 9 2021

Keywords

  • cardiovascular disease
  • diabetes mellitus, type 2
  • diabetic nephropathies
  • heart failure
  • kidney diseases
  • renal insufficiency, chronic

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this